Invention Grant
- Patent Title: Non-irritating, non-blurring, photostable ophthalmic sunscreen composition
-
Application No.: US15648107Application Date: 2017-07-12
-
Publication No.: US10695290B2Publication Date: 2020-06-30
- Inventor: A. Ebbie Soroudi
- Applicant: A. Ebbie Soroudi, M.D., M.S., A Professional Medical Corporation
- Applicant Address: US CA Los Angeles
- Assignee: A. EBBIE SOROUDI, M.D., M.S., A PROFESSIONAL MEDICAL CORPORATION
- Current Assignee: A. EBBIE SOROUDI, M.D., M.S., A PROFESSIONAL MEDICAL CORPORATION
- Current Assignee Address: US CA Los Angeles
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K33/30 ; A61K31/495 ; A61K31/4192 ; A61K31/215 ; A61Q17/04 ; A61K8/37 ; A61K8/29 ; A61K8/46 ; A61K8/49 ; A61K8/365 ; A61K8/27 ; A61K8/40 ; A61K8/35 ; A61K8/19 ; A61K8/28 ; A61K8/41 ; A61K8/44

Abstract:
A non-irritation, non-blurring, photostable ophthalmic sunscreen composition contains at least one of the following: bemotrizinol; bisoctrizole; tris-biphenyl triazine; and/or octyl methoxycinnamate. A liquid vehicle base is then a remainder of the solution by weight. The composition is an artificial tear formulation or an ophthalmic suspension or ointment. The composition may include at least one inorganic and/or at least one organic active ingredient. The inorganic active ingredients may include, but not be limited to zinc oxide, titanium dioxide, iron oxide, zirconium oxide, and cerium oxide. The organic active ingredients may include, but not be limited to dioxybenzone, octinoxate, octisalate, homosalate, avobenzone, octocrylene, para-aminobenzoic acid, cinoxate, methyl anthranilate, octocrylene, padimate O, ensulizole, sulisobenzone, trolamine salicylate, and ecamsule.
Public/Granted literature
- US20170304193A1 NON-IRRITATING, NON-BLURRING, PHOTOSTABLE OPHTHALMIC SUNSCREEN COMPOSITION Public/Granted day:2017-10-26
Information query